Shuttle Pharmaceuticals, Inc.

Launching the Next Generation of Radiation Oncology Treatments

Gaithersburg, United States · Founded 2015 · $1.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$1.0M
Last Round
$790K Seed
Rounds
2

About

Shuttle Pharmaceuticals is a clinical-stage company developing novel radiosensitizers and immunotherapy agents to improve outcomes for cancer patients receiving radiation therapy. Its lead candidate, Ropidoxuridine, is an orally available halogenated pyrimidine that sensitizes cancer cells to radiation, with applications in glioblastoma and other tumors. The company has a strategic research collaboration with Georgetown University.

Summary

Shuttle Pharmaceuticals, Inc. is a Biotech company based in Gaithersburg, United States, founded in 2015. It has raised $1.0M in total across 2 rounds. Investors include National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketMar 2026

Sign up to see all 5 rounds

Seed through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Shuttle Pharmaceuticals, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/shuttle-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/shuttle-pharmaceuticals-inc" alt="Shuttle Pharmaceuticals, Inc. on Indexed.vc" width="260" height="76" /></a>